Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szczypka, M. S.
Right arrow Articles by Humes, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szczypka, M. S.
Right arrow Articles by Humes, H. D.

Stem Cells 2005;23:44-54 www.StemCells.com
© 2005 AlphaMed Press

Rare Incorporation of Bone Marrow-Derived Cells Into Kidney After Folic Acid-Induced Injury

Mark S. Szczypkaa, Angela J. Westovera, Shawn G. Clouthierc, James L.M. Ferrarac, H. David Humesa,b,c

a Research Division, Nephros Therapeutics Inc., Ann Arbor, Michigan;
b University of Michigan Comprehensive Cancer Center and
c Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA

Key Words. Bone marrow transplant • Transdifferentiation • Kidney • Bone marrow-derived Folic acid • Adult stem cells • Acute renal failure

Correspondence: Mark S. Szczypka, 1995 Highland Drive, Suite F, Ann Arbor, MI 48108, USA. Telephone: 734–975–0080; Fax: 734–975–0090; e–mail: mszczypka{at}nephrostherapeutics.com

Results obtained in recent experiments suggest that bone marrow-derived cells (BMDCs) engraft into tissues and differentiate into various somatic cell types. However, it is unclear whether injury is required for the phenomenon to occur at appreciable frequencies. In this study we tested whether BMDCs engraft into kidneys and differentiate into renal cells in the absence or presence of toxic injury. Renal damage was induced by delivery of folic acid (FA) to bone marrow (BM)-recipient mice 1 or 9 months after bone marrow transplant, and kidneys were examined for donor-derived cells 2,4, or 8 weeks after injury. Donor-derived cells were abundant in the renal interstitium of injured kidneys and were detected in glomeruli of vehicle- and FA-treated mice. Most of these cells expressed the common leukocyte antigen CD45 and display morphological characteristics of white blood cells. No donor-derived renal tubule cells (RTCs) were detected in kidney sections of BM-recipient mice. However, in cell culture, a cluster of seven donor-derived cells of 4 x 106 RTCs examined (~ 0.0002%) displayed morphological characteristics of RTCs. CD45+ cells of donor origin were also detected in glomeruli and glomerular outgrowths. Nested polymerase chain reaction analysis for the male-specific Sry gene in cultured RTCs and glomerular outgrowths confirmed the presence of donor-derived cells. These results suggest that BMDCs may incorporate into glomeruli as specialized glomerular mesangial cells; however, BMDCs rarely contribute to the repair of renal tubules in uninjured or FA-treated mouse kidneys.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. Gupta, C. Verfaillie, D. Chmielewski, S. Kren, K. Eidman, J. Connaire, Y. Heremans, T. Lund, M. Blackstad, Y. Jiang, et al.
Isolation and Characterization of Kidney-Derived Stem Cells
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3028 - 3040.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J.-K. Guo, A. Schedl, and D. S. Krause
Bone Marrow Transplantation Can Attenuate the Progression of Mesangial Sclerosis
Stem Cells, February 1, 2006; 24(2): 406 - 415.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. Kim and G. R. Dressler
Nephrogenic Factors Promote Differentiation of Mouse Embryonic Stem Cells into Renal Epithelia
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3527 - 3534.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. C. Brodie and H. D. Humes
Stem Cell Approaches for the Treatment of Renal Failure
Pharmacol. Rev., September 1, 2005; 57(3): 299 - 313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2005 by AlphaMed Press.